Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways
Voltage-gated sodium channels (Na<sub>V</sub>s) are a key determinant of neuronal signalling. Neurotoxins from diverse taxa that selectively activate or inhibit Na<sub>V</sub> channels have helped unravel the role of Na<sub>V</sub> channels in diseases, including...
Main Authors: | Yashad Dongol, Fernanda C. Cardoso, Richard J. Lewis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/11/11/626 |
Similar Items
-
Structure–Function and Therapeutic Potential of Spider Venom-Derived Cysteine Knot Peptides Targeting Sodium Channels
by: Fernanda C. Cardoso, et al.
Published: (2019-04-01) -
Synthetic peptides to produce antivenoms against the Cys-rich toxins of arachnids
by: Silvia A. Camperi, et al.
Published: (2020-06-01) -
A Spider Toxin Exemplifies the Promises and Pitfalls of Cell-Free Protein Production for Venom Biodiscovery
by: Tim Lüddecke, et al.
Published: (2021-08-01) -
Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula
by: Chun Yuen Chow, et al.
Published: (2015-06-01) -
Addition of K22 Converts Spider Venom Peptide Pme2a from an Activator to an Inhibitor of Na<sub>V</sub>1.7
by: Kathleen Yin, et al.
Published: (2020-02-01)